Decibel Therapeutics, Inc. Common Stock
DBTX
DBTX was delisted on the 22nd of September, 2023.
40 hedge funds and large institutions have $45M invested in Decibel Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 6 closing their positions.
152% more call options, than puts
Call options by funds: $655K | Put options by funds: $260K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 11
5% less funds holding
Funds holding: 42 → 40 (-2)
17% less capital invested
Capital invested by funds: $54.4M → $45M (-$9.44M)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$319K |
| 2 |
Millennium Management
New York
|
+$240K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$188K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$185K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$75.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$228K |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$82K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$74K |
| 4 |
SWM
Spire Wealth Management
Mclean,
Virginia
|
-$70K |
| 5 |
MA
MYDA Advisors
Woodmere,
New York
|
-$63K |
DBTX Hedge Fund Activity: Q3 2022 in Review
40 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Decibel Therapeutics, Inc. Common Stock (DBTX) for Q3 2022, worth a combined $45M — down 17% from $54.4M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of DBTX and 4 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 10 added.
The largest buyer was UBS O'Connor, adding an estimated $319K. The largest seller was Bridgeway Capital Management, cutting an estimated $228K.
- 40 institutional investors held Decibel Therapeutics, Inc. Common Stock (DBTX) as of Q3 2022, down from 42 in Q2 2022.
- Funds reported $45M of Decibel Therapeutics, Inc. Common Stock stock for Q3 2022, down 17% quarter-over-quarter.
- 4 funds opened new Decibel Therapeutics, Inc. Common Stock positions in Q3 2022 and 6 closed out, a net change of -2 holders.
- The largest Decibel Therapeutics, Inc. Common Stock buyer in Q3 2022 was UBS O'Connor, an estimated $319K added.
- The largest Decibel Therapeutics, Inc. Common Stock seller in Q3 2022 was Bridgeway Capital Management, an estimated $228K sold.
Based on aggregated 13F filings for Q3 2022.